HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells

MLA

Guylène Firaguay, et al. “HCV Glycoprotein E2 Is a Novel BDCA-2 Ligand and Acts as an Inhibitor of IFN Production by Plasmacytoid Dendritic Cells.” Blood, vol. 120, no. 23, Oct. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0aa8616da2badd2e099d3cbe81fcdadf&authtype=sso&custid=ns315887.

APA

Guylène Firaguay, Christine Thumann, Vassili Soumelis, Ruzena Wiersum Stranska, Besma Aouar, Thomas F. Baumert, Ivan Hirsch, Françoise Gondois-Rey, Clelia Dental, Daniel Olive, Jacques A. Nunès, & Jonathan Florentin. (2012). HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Blood, 120(23).

Chicago

Guylène Firaguay, Christine Thumann, Vassili Soumelis, Ruzena Wiersum Stranska, Besma Aouar, Thomas F. Baumert, Ivan Hirsch, et al. 2012. “HCV Glycoprotein E2 Is a Novel BDCA-2 Ligand and Acts as an Inhibitor of IFN Production by Plasmacytoid Dendritic Cells.” Blood 120 (23). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0aa8616da2badd2e099d3cbe81fcdadf&authtype=sso&custid=ns315887.